The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia Patients
Phase 3
Recruiting
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20211219053452N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Schizophrenia
Get a score of 61 or higher on the panss questionnaire
Exclusion Criteria
Simultaneous presence of other neurological disorders
Any allergy to atomoxetine
Patients who have received ECT in the last 6 weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wechsler Short-Term Memory Test. Timepoint: Before the intervention and after 8 weeks of treatment. Method of measurement: Wechsler test.
- Secondary Outcome Measures
Name Time Method Short-term memory expansive score, direct visual memory, reverse visual memory, direct auditory memory, auditory reverse memory. Timepoint: Before the intervention and after 8 weeks of treatment. Method of measurement: How to measure short-term memory, direct visual memory, reverse visual memory, direct auditory memory, auditory reverse memory using Wechsler test.